Further examination of PACAP levels in PD patients at distinct therapeutic stages of the disease revealed significant differences in the concentrations of the peptide, with lower values observed at advanced stages of the disorder (Pham et al. 2022). The gene discussed is ADCYAP1; the disease is Parkinson disease.